Skip to content
Saturday 5 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,831.09
0.00%
DAX
26,046.40
+0.17%
CAC 40
8,278.77
-0.09%
STOXX 50
6,392.93
+0.16%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 02 September 2013 8:11 pm

Letters to the editor for – 03/09 – UK risk disease, Help to Buy, Best of Twitter

By: Express KCS

Add as a preferred source on Google

UK risk disease

[Re: Both Left and Right should fear the threat to medical research in the UK, yesterday]

London has the capacity to build a world class cluster for biomedical innovation. But John Hulsman highlights a stark example of a risk averse culture in this country – a disease we need to treat if we are to deliver on our potential. There are signs of promise. The Francis Crick Institute, due for completion in London in 2015, will attract scientists and clinicians, facilitating the translation of discovery into treatments. But regulators, financiers, government and researchers must work together to deliver – for the health of both our citizens and our economy.

Professor Stephen Caddick, vice-provost, UCL

………………..

Help to Buy

[Re: Demand for houses rises as Help to Buy takes flak, yesterday]

One way the government can make housing more affordable is to switch stamp duty to sellers, rather buyers. First time buyers would no longer have the burden of saving for the duty as well as the deposit. This could stimulate the market, as most chain purchases are reliant on those at the bottom – usually the first time buyer. This method should make no difference to those in the middle of the chain. The government only needs to make exceptions for those at the top end of the chain, or who have recently purchased.

Richard Emms

………………..

BEST OF TWITTER

There should be no second vote on Syria unless there is a major change in circumstances.
@DanHannanMEP

Last time UK manufacturing output was growing this fast (1994), GDP was growing at 4.5 per cent.
@AndrewLilico

Strong growth and persistent above target inflation – surely a case for moving interest rates off the floor.
@asentance

Drone strikes insufficiently troublesome for Obama to request Congress’ approval. Syria, on the other hand.
@ianbremmer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Opinion

Categories

  • Opinion

Trending Articles

  • Victoria Beckham owed £350,000 by Harvey Nichols

  • M&G: FTSE 100 giant hits out at Rayner’s ground rent cap as it suffers loss

  • John Lewis boss: UK economy facing a ‘permacrisis’ 

  • Fulham owner Khan sees his £1bn stadium construction project take next steps

  • Labour calls for Mayor to explore London Stadium sale to West Ham

More from Morning Wire

  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • The European fintech American dream is being called into question

    Fintech
    Wise logo with downward trending stock chart, highlighting fintechs share decline amid Belgium fraud investigation
  • West Ham: Staveley receives Sadiq Khan encouragement to buy London Stadium

    Sport Business
    Low-angle view of a football stadium from the pitch, showing the corner marking and empty seats under a blue sky
  • Silence Therapeutics to Participate in Three September Investor Conferences

    Business Wire
  • Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

    Business Wire
  • Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook